Precigen (PGEN) Free Cash Flow (2012 - 2026)

Precigen (PGEN) has 15 years of Free Cash Flow data on file, last reported at -$44.1 million in Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$44.1 million, down 160.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$115.2 million (down 48.61% YoY), and the FY2025 annual result was -$88.0 million, down 14.71% from the prior year.
• Free Cash Flow declined to -$44.1 million in Q1 2026 per PGEN's latest filing, from -$23.2 million in the prior quarter.
• Over five years, Free Cash Flow peaked at -$10.1 million in Q2 2022 and troughed at -$44.1 million in Q1 2026.
• A 5-year average of -$20.4 million and a median of -$18.5 million in 2023 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2025 and 2026: Free Cash Flow grew 27.93% in 2025, then slumped 160.13% in 2026.
• A 5-year view of Free Cash Flow shows it stood at -$20.1 million in 2022, then rose by 21.27% to -$15.8 million in 2023, then decreased by 1.6% to -$16.1 million in 2024, then slumped by 44.19% to -$23.2 million in 2025, then tumbled by 89.97% to -$44.1 million in 2026.
• Business Quant data shows PGEN's Free Cash Flow at -$44.1 million in Q1 2026, -$23.2 million in Q4 2025, and -$27.9 million in Q3 2025.